high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy

KCE Sigaloff, J Kayiwa, V Musiime… - AIDS research and …, 2013 - liebertpub.com
HIV-infected children are at high risk of acquiring drug-resistant viruses, which is of
particular concern in settings where antiretroviral drug options are limited. We aimed to …
被引用次数：25 相关文章

[引用][C] High Rates of Thymidine Analogue Mutations and Dual-Class Resistance Among HIV-Infected Ugandan Children Failing First-Line Antiretroviral Therapy

KCE Sigaloff, J Kayiwa, V Musiime, JCJ Calis… - AIDS Research and …, 2013 - cir.nii.ac.jp
Short Communication: High Rates of Thymidine Analogue Mutations and Dual-Class
Resistance Among HIV-Infected Ugandan Children Failing First-Line Antiretroviral Therapy …
[PDF] academia.edu

[PDF][PDF] High Rates of Thymidine Analogue Mutations and Dual-Class Resistance Among HIV-Infected Ugandan Children Failing First-Line Antiretroviral Therapy

KCE Sigaloff, J Kayiwa, V Musiime… - AIDS RESEARCH …, 2013 - academia.edu
HIV-infected children are at high risk of acquiring drug-resistant viruses, which is of
particular concern in settings where antiretroviral drug options are limited. We aimed to …

high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy.

KC Sigaloff, J Kayiwa, V Musiime, JC Calis… - AIDS Research and …, 2013 - europepmc.org
HIV-infected children are at high risk of acquiring drug-resistant viruses, which is of
particular concern in settings where antiretroviral drug options are limited. We aimed to …
[PDF] uva.nl

[PDF][PDF] High rates of thymidine analogue muta-tions and dual-class resistance among HIV-infected Ugandan children fail-ing first-line antiretroviral therapy

KCE Sigaloff, J Kayiwa, V Musiime, JCJ Calis… - HIV drug resistance … - dare.uva.nl
Methods HIV-RNA determination and genotypic resistance testing on all specimens with HIV-
RNA> 1000 copies/ml was performed. Major drug resistance mutations were scored using …

High rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy.

KCE Sigaloff, J Kayiwa, V Musiime, JCJ Calis… - 2013 - cabidigitallibrary.org
HIV-infected children are at high risk of acquiring drug-resistant viruses, which is of
particular concern in settings where antiretroviral drug options are limited. We aimed to …
[PDF] researchgate.net

[PDF][PDF] High Rates of Thymidine Analogue Mutations and Dual-Class Resistance Among HIV-Infected Ugandan Children Failing First-Line Antiretroviral Therapy

KCE Sigaloff, J Kayiwa, V Musiime… - AIDS RESEARCH …, 2013 - researchgate.net
HIV-infected children are at high risk of acquiring drug-resistant viruses, which is of
particular concern in settings where antiretroviral drug options are limited. We aimed to …
[PDF] uva.nl

[PDF][PDF] High rates of thymidine analogue muta-tions and dual-class resistance among HIV-infected Ugandan children fail-ing first-line antiretroviral therapy

KCE Sigaloff, J Kayiwa, V Musiime, JCJ Calis… - HIV drug resistance … - pure.uva.nl
Methods HIV-RNA determination and genotypic resistance testing on all specimens with HIV-
RNA> 1000 copies/ml was performed. Major drug resistance mutations were scored using …

High rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy

KCE Sigaloff, J Kayiwa… - AIDS …, 2013 - researchinformation.amsterdamumc …
HIV-infected children are at high risk of acquiring drug-resistant viruses, which is of
particular concern in settings where antiretroviral drug options are limited. We aimed to …

high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy

KCE Sigaloff, J Kayiwa, V Musiime… - AIDS research and …, 2013 - pubmed.ncbi.nlm.nih.gov
HIV-infected children are at high risk of acquiring drug-resistant viruses, which is of
particular concern in settings where antiretroviral drug options are limited. We aimed to …